FI972637A0 - Use of vitamin K in the treatment of hyperthyroidism - Google Patents

Use of vitamin K in the treatment of hyperthyroidism

Info

Publication number
FI972637A0
FI972637A0 FI972637A FI972637A FI972637A0 FI 972637 A0 FI972637 A0 FI 972637A0 FI 972637 A FI972637 A FI 972637A FI 972637 A FI972637 A FI 972637A FI 972637 A0 FI972637 A0 FI 972637A0
Authority
FI
Finland
Prior art keywords
hyperthyroidism
vitamin
treatment
Prior art date
Application number
FI972637A
Other languages
Finnish (fi)
Swedish (sv)
Other versions
FI972637A (en
Inventor
Martin Kohlmeier
Joerg Saupe
Original Assignee
Bartz Volker
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bartz Volker filed Critical Bartz Volker
Publication of FI972637A0 publication Critical patent/FI972637A0/en
Publication of FI972637A publication Critical patent/FI972637A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FI972637A 1994-12-22 1997-06-19 Use of vitamin K in the treatment of hyperparathyroidism FI972637A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4446024A DE4446024C2 (en) 1994-12-22 1994-12-22 Use of a vitamin from the K group
PCT/DE1995/001824 WO1996019208A1 (en) 1994-12-22 1995-12-20 Use of a vitamin of the k group for treating hyperparathyroidism

Publications (2)

Publication Number Publication Date
FI972637A0 true FI972637A0 (en) 1997-06-19
FI972637A FI972637A (en) 1997-06-26

Family

ID=6536748

Family Applications (1)

Application Number Title Priority Date Filing Date
FI972637A FI972637A (en) 1994-12-22 1997-06-19 Use of vitamin K in the treatment of hyperparathyroidism

Country Status (5)

Country Link
JP (1) JPH11500709A (en)
AU (1) AU4297696A (en)
DE (1) DE4446024C2 (en)
FI (1) FI972637A (en)
WO (1) WO1996019208A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20170318837A1 (en) * 2014-12-17 2017-11-09 Hill's Pet Nutrition, Inc. Method and Composition for Reducing Hyperthyroidism
WO2017210467A1 (en) * 2016-06-02 2017-12-07 Ana Pharmaceuticals, Inc. Methods and compositions for treatment of hypercalciuria and nephrolithiasis

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2704393B1 (en) * 1993-04-30 1995-06-02 Boiron Absorbable nutritional supplement to optimize growth and maintain strong bones.

Also Published As

Publication number Publication date
FI972637A (en) 1997-06-26
WO1996019208A1 (en) 1996-06-27
AU4297696A (en) 1996-07-10
DE4446024A1 (en) 1996-06-27
JPH11500709A (en) 1999-01-19
DE4446024C2 (en) 1997-01-23

Similar Documents

Publication Publication Date Title
FI970762A0 (en) Spido-azabicyclic compounds useful in therapy
CY2007001I1 (en) MEDICINAL PREPARATION FOR USE IN THE TREATMENT OF DIABETES
ID28981A (en) HEKSANA 3-AZABISIKLO (3.1.0) USES IN THERAPY
DE69524138D1 (en) Skin treatment agents
CY2508B1 (en) Benzopyrans and their use as therapeutic agents
ID16283A (en) COMFORT USED IN PHARMACEUTICAL
BR9506389B1 (en) silicon, and dietary, cosmetic and therapeutic composition.
ID16981A (en) THE CONCENTRATES OF ENCER PEARLS
FI972637A0 (en) Use of vitamin K in the treatment of hyperthyroidism
IS5324A (en) (S) 2-Methylamino-2-phenyl-n-butyl 3,4,5-trimethoxy-benzoate, its use in the treatment of chronic pain
TR199501530A1 (en) Kit for use in the therapeutic cycle in the treatment of osteoporosis.
KR950026706U (en) Treatment fever
MD281F1 (en) Magnetodynamic massage
KR950008161U (en) Personal poultice sauna
KR960003833U (en) Safety chair
KR960009996U (en) Massage footrest
FI954912A0 (en) Use of ceruletide-ditylamine salt in the treatment of psoriasis
ITRM940184A0 (en) USE OF ACETYL-L-CARNITINE IN THE DETOXIFICATION OF NICOTINE
BR9401255A (en) Portable set for dental treatment
ID15808A (en) USE OF PROTEASE IN THE MEDICINE
SI1011649T1 (en) Use of endipalene in the treatment of psoriasis
LV5035A3 (en) Preparation for the prevention and treatment of endometritis in cows
ZA954732B (en) Benzopyrans and their use as therapeutic agents
UA25095A (en) LIMITATION FOR THE TREATMENT OF CANDIDOUS AND MIXED VULVOVAGITIS
SE9300795D0 (en) NEW PRINCIPLE FOR PAIN TREATMENT

Legal Events

Date Code Title Description
FD Application lapsed